VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. enters ORUKA THERAPEUTICS, INC. with 4.03M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 2/27/2025ACC: 0001415889-25-005906
→
10% Owner
Since Feb 2025
4.03M
Baseline shares
0.00
Direct ownership
0 positions
524.54K
Derivative underlying
2 instruments
1
Security positions
4.03M indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned4.03M
Total
4.03M indirect4.03M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.03M | Indirect |
| Total | 4.03M | 4.03M indirect |
Derivative Holdings2
Pre-Funded Warrants (Right to Buy)
IndirectUnderlying security
Common Stock
Underlying shares
300K
Shares owned
N/A
Exercise price
0.001
Expiration
—
Exercise window
—
Pre-Funded Warrants (Right to Buy)
IndirectUnderlying security
Common Stock
Underlying shares
224.54K
Shares owned
N/A
Exercise price
0.01
Expiration
—
Exercise window
—
Total
Underlying
524.54K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Pre-Funded Warrants (Right to Buy) Indirect | Common Stock | 0.001 | — | — | 300K | N/A |
| Pre-Funded Warrants (Right to Buy) Indirect | Common Stock | 0.01 | — | — | 224.54K | N/A |
| Total | 524.54K | 0.00 | ||||